To investigate whether SHP-1 can regulate αmβ2 integrinmediated adhesion, bone marrow derived macrophages from normal, CD45 -/-, me v mice or mice deficient in both CD45 and SHP-1 (CDm) were replated and allowed to readhere, an event dependent upon αmβ2 integrin adhesion [5, 6] . After 24 hours, the majority of mature macrophages from normal mice were adherent; however, a substantial fraction were refractile with minimal spreading (Figure 1a) . As we reported previously [5], CD45-deficient macrophages were almost entirely detached due to accelerated de-adhesion (Figure 1a) . In contrast, macrophages from both me v and CDm mice were adherent and markedly spread (Figure 1a) . Quantitation of adherent cell areas of single cells plated at low density revealed that CD45-deficient macrophages were significantly less spread than normal macrophages (Figure 1b) . However, both me v and CDm cells showed significantly increased adhesion and spreading when compared with normal macrophages (Figure 1b ). This demonstrates that catalytically active SHP-1 is required for the previously reported spontaneous de-adhesion observed in CD45-deficient macrophages [5] . Compared with normal macrophages, it is likely that the increased spreading in me v and CDm macrophages reflects perturbation of a dynamic balance between adhesion and de-adhesion which requires SHP-1. Furthermore, the data suggest that SHP-1 phosphatase activity is necessary for and downstream of CD45's regulation of adhesion.
Results and discussion
To investigate whether SHP-1 can regulate αmβ2 integrinmediated adhesion, bone marrow derived macrophages from normal, CD45 -/-, me v mice or mice deficient in both CD45 and SHP-1 (CDm) were replated and allowed to readhere, an event dependent upon αmβ2 integrin adhesion [5, 6] . After 24 hours, the majority of mature macrophages from normal mice were adherent; however, a substantial fraction were refractile with minimal spreading (Figure 1a) . As we reported previously [5] , CD45-deficient macrophages were almost entirely detached due to accelerated de-adhesion ( Figure 1a ). In contrast, macrophages from both me v and CDm mice were adherent and markedly spread ( Figure 1a) . Quantitation of adherent cell areas of single cells plated at low density revealed that CD45-deficient macrophages were significantly less spread than normal macrophages ( Figure 1b ). However, both me v and CDm cells showed significantly increased adhesion and spreading when compared with normal macrophages (Figure 1b ). This demonstrates that catalytically active SHP-1 is required for the previously reported spontaneous de-adhesion observed in CD45-deficient macrophages [5] . Compared with normal macrophages, it is likely that the increased spreading in me v and CDm macrophages reflects perturbation of a dynamic balance between adhesion and de-adhesion which requires SHP-1. Furthermore, the data suggest that SHP-1 phosphatase activity is necessary for and downstream of CD45's regulation of adhesion.
The p85/p110 PI 3-kinase can be activated by integrin adhesion [7] [8] [9] and can regulate cytoskeletal rearrangement controlling cell spreading and adhesion [10, 11] . The PI D-3 lipids, PI 3,4-bisphosphate, (PI(3,4)P 2 ) and PI 3,4,5-trisphosphate (PI(3,4,5)P 3 ) are the main products of PI 3-kinase activation in vivo [12] . Hence, to determine whether PI 3-kinase activity was deregulated in the absence of catalytically active SHP-1, we examined levels of PI lipids produced by adherent normal, CD45-deficient, me v and CDm macrophages following metabolic labeling of cells with 32 [P i ]. When normalized to total phospholipid content, me v and CDm macrophages exhibited more than 10-15-fold higher levels of D-3 phospholipids (Figure 2a) , indicating a higher level of PI 3-kinase activity at the membrane. This was not due to different expression patterns of the p110α, β or γ subunits in the macrophages of different genotypes (data not shown). In contrast, levels of PI and PI(4,5)P 2 were similar to normal in me v and CDm macrophages (Figure 2 ).
To determine whether the increased adhesion and spreading observed in me v or CDm macrophages was dependent upon PI 3-kinase activity, macrophages were treated with wortmannin, an inhibitor of PI 3-kinase [13] (Figure 3a) . Low concentrations of wortmannin (20 nM) led to de-adhesion of macrophages of all genotypes within 1 hour (Figure 3a and data not shown). LY294002, a PI 3-kinase inhibitor with a mode of action distinct from that of wortmannin [14] , also induced de-adhesion at 20 µM (data not shown). These data show that maintenance of PI 3-kinase activity is required for continued macrophage adhesion and support the conclusion that SHP-1 regulation of PI 3-kinase is important for its modulation of macrophage adhesion and spreading.
Membrane localization of PI 3-kinase is required for enzyme activity because translocation of PI 3-kinase allows access to phospholipid substrate, and interactions of the p85 regulatory subunit with other proteins may regulate a conformational activation of the p110 catalytic subunit [12, 15] . PI 3-kinase immunoprecipitated (by antip85) from normal and me v whole-cell lysates showed similar activities in in vitro assays (data not shown). However, fractionation of the cells into membrane and cytosol and immunoprecipitation with anti-p85 revealed that me v macrophages had a 2-5-fold increase in the proportion of PI 3-kinase activity associated with membranes ( Figure 3b and data not shown).
The me v disease is characterized by excessive idiopathic inflammation as well as increased production of myeloid cells, including extramedullary hematopoiesis. The unregulated inflammation leads to skin disease, arthritis and pneumonitis, eventually ending in death of the animal. Inflammation can be inhibited by blocking αmβ2, the predominant myeloid integrin, suggesting that regulation of adhesion has a prominent role in me v disease [16] . We found that deficiency of SHP-1 induces enhanced αmβ2-mediated adhesion, regardless of whether or not CD45 is expressed by the macrophages. The spontaneous detachment from αmβ2-mediated contacts that occurs to some extent in normal macrophages, and is dramatically increased in the absence of CD45, is abrogated by a deficiency of SHP-1. As me v mice express a catalytically impaired SHP-1 protein, this finding demonstrates that SHP-1 phosphatase activity is required for normal regulation of macrophage de-adhesion.
The mechanism by which SHP-1 activates de-adhesion probably requires that it regulate PI 3-kinase. The me v and CDm macrophages have markedly increased D-3 phospholipid levels, indicating enhanced PI 3-kinase activity in vivo, and PI 3-kinase inhibitors cause detachment of normal and SHP-1-deficient macrophages from αmβ2-integrin-mediated contacts. Because total cellular PI 3-kinase activity is not affected by SHP-1 deficiency, but membrane-associated PI 3-kinase is markedly increased in its absence, it is specifically the membrane-associated pool of PI 3-kinase which is regulated by SHP-1. Although this is a minority of whole-cell PI 3-kinase protein, it is probably the physiologically important pool of enzyme as it is associated with substrate.
Mice deficient in the SH2-containing inositol phosphatase SHIP have a remarkably similar phenotype to me v mice, with an accumulation of macrophages and neutrophils in the lung and a shortened life span [17] . It has been shown in cell lines that inhibitory signaling following specific receptor recruitment of SHIP or SHP-1 can function via independent receptor pathways [18] . Our data suggest that SHP-1 regulates the level of PI D-3 lipids through the control of PI-3 kinase activation. Thus, pathways inhibited by SHP-1 and SHIP may converge at the level of regulation of phosphorylated phosphatidylinositol lipids. The similar phenotypes of me v mice and SHIP-deficient mice suggest that it is deregulation of phosphatidylinositol phosphorylation that contributes significantly to the idiopathic inflammation in both mouse strains.
CD45 and SHP-1 have been proposed to have opposing effects on lymphocyte activation [19] . If the same were true for myeloid activation, or if the inflammatory disease of me v mice was due to a primary abnormality in lymphocyte signaling, CD45 deficiency should ameliorate the disease of me v mice. However, CDm mice present a disease pathology indistinguishable from that of me v mice, with involvement of skin, thymus, spleen, kidney and lungs (unpublished observations). Together with data demonstrating that a blockade of αmβ2 interaction slows the me v disease in a bone marrow chimeric model [16] , these data strongly suggest that the failure to regulate macrophage deadhesion normally may be critical for the spontaneous inflammation that characterizes the me v disease. We propose that the pathologic accumulation of leukocytes in lung and other tissues of me v and CDm mice results in part from the failure to properly regulate leukocyte de-adhesion. Normal migration of phagocytes into tissues is accompanied by integrin activation and enhanced adhesion, a reversible process [20] [21] [22] . After migration of macrophages out of the vasculature and into tissue at sites of inflammation, the regulation of macrophage adhesion is likely to be key to the control of macrophage survival and activation at these sites. The failure of me v and CDm macrophages to Brief Communication 1037 regulate adhesion and spreading appropriately, as shown in our in vitro studies, and the hyperactivation of PI 3-kinase, could be central to the in vivo accumulation of macrophages in tissue in SHP-1-deficient mice [23] . In conclusion, these studies have elucidated a novel function for SHP-1 -the regulation of integrin-mediated adhesion through regulation of the function of PI 3-kinase. Pathologic deregulation of this interaction leads to inflammation and is a likely biochemical target for intervention to control the idiopathic and excessive inflammation that characterizes human autoimmune diseases.
Supplementary material
Additional methodological details are published with this paper on the internet.
The protein tyrosine phosphatase SHP-1 regulates integrinmediated adhesion of macrophages 
Materials and methods

Mice
All mice were maintained according to NIH guidelines in a specific pathogen-free barrier facility. Breeding pairs of me v mice were purchased from Jackson Laboratory and maintained in our facility for greater than 3 years by crossing heterozygous pairs. The presence of the me v allele was determined by PCR as previously described [S1]. The derivation of the CD45-deficient animals has been described previously [S2] . CD45-deficient mice were backcrossed to B6 mice for at least nine generations and maintained as homozygous mice. To generate mice deficient in both SHP-1 and CD45, me v mice were crossed to CD45-deficient mice to generate mice heterozygous for each allele. Doubly heterozygous mice were crossed to CD45 -/-mice to generate mice that were heterozygous for the me v allele and homozygous for the CD45-gene targeted allele. CDm mice were generated by crossing heterozygous me v , CD45 -/-mice. Mice were from 4 to 12 weeks of age, and were sex-and agematched (within 2 weeks of age) within experiments.
Adhesion
Macrophages were differentiated from bone marrow precursors and maintained in culture as previously described [5] . Briefly, bone marrow derived macrophages were differentiated from promonocytes plated at 5 × 10 8 to 1 × 10 7 cells per dish on non-tissue culture treated plastic (Valmark 'ultradish', Midwest Scientific) in high-glucose Dulbecco's modified Eagle's medium (DMEM; Gibco-BRL), with 10% fetal bovine serum (FBS; HyClone Labs), 20 mM HEPES, and 15% L929 cell-conditioned supernatant as a source of M-CSF. Mature bone marrow macrophages were harvested from day 6 to day 15 in PBS containing 10 mM EDTA. Wortmannin and LY294002 were dissolved in DMSO and used at final concentrations of 1-20 nM or 5-20 µM, respectively.
Immunoprecipitations and kinase reactions
Macrophages, 3-8 × 10 6 cells per point, were lysed in ice cold Trisbuffered saline (150 mM NaCl, 50 mM Tris-HCl pH 7.5) containing 1% Triton X-100 (Pierce), 1% deoxycholate, 1 mM EDTA (lysis buffer), with 10 µg/ml leupeptin, 10 µg/ml aprotinin, 1 mM NaF, 200 µM pervanadate and 2 mM diisopropyl-fluorophosphate (all chemicals from Sigma). Nuclei and debris were removed by centrifugation and supernatants collected. Lysates were precleared with protein A (or G)-Sepharose coupled to normal rabbit IgG or whole serum. Immunoprecipitations were performed using protein A/G coupled to rabbit IgG against SHP-1 or whole rabbit serum anti-p85 (#06-195, UBI) or SHP-1 [S3] .
Immunoprecipitates collected by centrifugation were washed three times in lysis buffer with inhibitors and resolved by SDS-PAGE.
